• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

NIVOLUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

INTERFERON COVID-19 ACE IL1B LACTATE DEHYDROGENASE IMMUNITY METFORMIN INSULIN IMMUNE RESPONSE MYALGIA IL2 HELICOBACTER PYLORI ANGIOTENSIN II INFLAMMATION RAS SARS-COV-2 ALZHEIMER'S DISEASE COAGULATION ESCHERICHIA COLI STAPHYLOCOCCUS AUREUS IL10 APOPTOTIC PROCESS LISTERIA MONOCYTOGENES ACE2 PARKINSON DISEASE AGING IL6 TNF CASP3 INFLAMMATORY RESPONSE CELL DIFFERENTIATION RHEUMATOID ARTHRITIS CELL PROLIFERATION COGNITION PSEUDOMONAS AERUGINOSA NFKB1 CANDIDA ALBICANS CANCER AUTOPHAGY TMPRSS2 ALBUMIN NEUTROPHILS IFNG PD-1 CD4

© 2021 Biovista Vizit All Rights Reserved.